SFS
GTHX

Sowell Financial Services’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Sowell Financial Services’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-2,381
Closed -$47K – 2884
2021
Q1 		$47K Sell
2,381
-719
-23% -$16.7K ﹤0.01% 1687
2020
Q4 		$56K Hold
3,100
– – ﹤0.01% 1354
2020
Q3 		$36K Buy
+3,100
New +$51.2K ﹤0.01% 1324

Other funds holding GTHX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
LOAMS
Lombard Odier Asset Management (Switzerland) Petit-Lancy, Switzerland $2.63B AUM 31.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Sowell Financial Services's GTHX Position: Q2 2021 in Review

Sowell Financial Services sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q2 2021, closing a stake of 2,381 shares — an estimated $47K sold.

Sowell Financial Services first reported a position in GTHX in Q3 2020 and held it in 3 quarters. The position peaked at $56K in Q4 2020. 114 funds tracked by Wall St. Rank hold GTHX as of Q2 2021.

  • Sowell Financial Services reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q2 2021 after selling out during the quarter.
  • Sowell Financial Services sold 2,381 G1 Therapeutics, Inc. Common Stock shares in Q2 2021, an estimated $47K.
  • Sowell Financial Services first reported a position in G1 Therapeutics, Inc. Common Stock in Q3 2020 and held it in 3 quarters.
  • Sowell Financial Services's G1 Therapeutics, Inc. Common Stock position peaked at $56K in Q4 2020.
  • 114 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q2 2021.

Based on Sowell Financial Services's 13F filing for Q2 2021, filed 5 Aug 2021.